deliVERy of Optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria - Trial PACTR202107579572114
Access comprehensive clinical trial information for PACTR202107579572114 through Pure Global AI's free database. This Not Applicable trial is sponsored by The George Institute for Global Health and is currently Not yet recruiting. The study focuses on Cardiology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
drug
Sponsor & Location
The George Institute for Global Health
National Health and Medical Research Council NHMRC
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
High blood pressure (BP) is the leading cause of preventable morbidity and mortality globally. The benefits of BP lowering in reducing cardiovascular (CV) events are well established and there is clear evidence that greater BP lowering confers a greater reduction in CV events. However, control of high BP is poor globally. It is estimated that in SSA on average only 7% achieved BP control. This study is undertaken to investigate, among Black African adults with high BP, who are untreated or receiving monotherapy, if a triple single pill combination-based treatment protocol compared to the Nigeria hypertension treatment protocol is efficacious, safe, and feasible to implement for improving BP control in Nigeria.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202107579572114
Non-Device Trial